Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers
Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers have?
Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers published?
Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has 2025 year in the ScholarIQ index.
What is the open-access status of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?
Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers has gold oa status in the ScholarIQ index.
What is the DOI of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?
The DOI for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.
What is the PMID of Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?
The PMID for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.
What is the OpenAlex record for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers?
The OpenAlex for Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers is on the source record.